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Background: Viral infections are thought to play a role in the development of autoimmune diseases
like type 1 diabetes. In this study we investigated the effect of Rat Cytomegalovirus (RCMV) infection
on cellular immunity in a well-deﬁned animal model for diabetes, the Biobreeding (BB) rat.
Methods: Diabetes prone (DP)- and Diabetes resistant (DR)-BB rats were infected with 2 £ 10
6
plaque forming units (pfu) RCMV. Diabetes development was monitored by frequent blood-glucose
analysis. Effects of RCMV on CD4
þ, CD8
þ and Vb-TCR
þ T-cell subsets were measured in vivo, and
in vitro after restimulation with RCMV-infected ﬁbroblasts. Proliferative capacity was determined by
3H-Thymidine incorporation.
Results: RCMV-infection resulted in a signiﬁcant acceleration of diabetes onset in DP-BB rats
ðp ¼ 0:003Þ. Percentages CD4
þ and CD8
þ T-cells were not affected in vivo. In vitro, RCMV-
restimulation resulted in a decreased CD4
þ/CD8
þ blastoid T-cell ratio compared to ConA
ðp ¼ 0:00028Þ. Furthermore, RCMV-restimulation resulted in a strong RCMV-speciﬁc proliferation,
which comprises about 50% of the response triggered by ConA. Vb-TCR percentages did not change
upon RCMV-infection or RCMV-restimulation.
Interpretation: RCMV-restimulation of splenic T-cells in vitro resulted in a strong RCMV-speciﬁc
proliferation, probably also including autoreactive T-cells. In vivo, this polyclonal response might be
involved in the observed accelerated diabetes development in DP-BB rats upon RCMV-infection.
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INTRODUCTION
Most autoimmune diseases (AID) have been shown to
have a strong genetic component. However, studies on
monozygous twins showed, that only in 50% of the cases
both siblings developed an AID of the same type
(McFarland, 1992; Kumar et al., 1993). These data
indicate that while AID occur in genetically susceptible
individuals, many other factors must be involved in the
phenotypic expression of autoimmunity (Rouse and
Deshpande, 2002). Such non-genetic factors are environ-
mental components, dietary constituents and infectious
agents, particularly viruses. A variety of human viruses
have been reported to be associated with AID. In Multiple
Sclerosis (MS), one of the most common AID, both lesion
induction and recurrence have been associated with many
viruses (Whitton and Fujinami, 1999; Olson et al., 2001).
However, no particular virus has deﬁnitively been shown
as the causative factor for MS disease. Autoimmune
diabetes type 1 is another AID in which several viruses are
suspected to play a role in the etiology, including
CoxsackieB virus, rubella virus and mumps virus (Jun and
Yoon, 2001). Another virus, which is thought to play
a role in AID and in particular autoimmune diabetes,
is Cytomegalovirus (CMV). This double stranded DNA
virus, which is widely spread in the human population,
causes a latent and persistent infection. In immuno-
competent individuals primary CMV infections generally
pass without clinical symptoms, whereas in immunocom-
promised hosts primary infections and reactivation of the
virus cause severe morbidity and mortality (Plummer,
1973; Sinzger and Jahn, 1996). Several reports have
suggested an association between CMV infection and
autoimmunity. For instance, CMV infection is considered
to be the most common viral antecedent infection of
patients with Guillain–Barre syndrome (GBS). Jacobs
et al. found a strong association of anti-GM2 IgM
antibodies and CMV infection in GBS patients (Jacobs
et al., 1997). Since Ang et al. showed, that CMV infected
human ﬁbroblasts express the GM2 epitope (Ang et al.,
2000), these ﬁndings support the hypothesis of molecular
mimicry between GM2 and CMV antigens as possible
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between the presence of CMV genome and islet cell
autoantibodies in newly diagnosed type 1 diabetic
patients, suggesting an association between human type
1 diabetes and CMV infection (Pak et al., 1988).
Atherosclerosis is also associated with CMV infection.
Adam et al. demonstrated in a clinical study that patients
with high titres of CMV antibodies had a greater risk of
developing clinically relevant atherosclerotic lesions
(Adam et al., 1987). In addition, CMV seropositive
transplant patients are at substantially higher risk of
suffering arterial occlusion, with subsequent graft loss or
rejection, compared to CMV seronegative controls
(Grattan et al., 1989; Pouria et al., 1998). Although
there is a lot of data supporting a role for viruses such as
CMV in autoimmune pathology, a causal relationship
remains very difﬁcult to demonstrate. One of the problems
is that individuals might have encountered multiple viral
infections at the time of diagnosis. Another problem is that
immunological mediated damage might occur only after
the viral infection has been cleared (von Herrath, 2000).
Animal models could provide more direct evidence on the
role of viral infections in AID. For instance, Semliki
Forest Virus (SFV) infection of mice is one of the most
useful experimental viral models of MS. SFV gives rise to
an acute virus infection of the central nerve system (CNS),
followed by demyelination. Mokhtarian et al., (1999)
reported that the virus exhibits molecular mimicry
with a peptide of myelin oligodendrocyte glycoprotein
(MOG). The antibody response against this epitope
may well contribute to autoimmune mediated injury to
CNS myelin.
The Diabetes prone (DP-BB) rat is a well-established
model of autoimmune diabetes in rats (Crisa et al.,
1992). The animals develop autoimmune diabetes
spontaneously at the age of 10–14 weeks. The diabetic
syndrome, which in many aspects resembles human
type 1 diabetes, results from the destruction of the
pancreatic b cells by an autoimmune mediated process
(Greiner et al., 2001). Co-isogenic Diabetes resistant
(DR) BB rats do not spontaneously develop auto-
immune diabetes. However, when DR-BB rats are
infected with Kilham Rat Virus (KRV), one-third of the
infected animals developed autoimmune diabetes
(Guberski et al., 1991). Chung et al. showed that
KRV-induced autoimmune diabetes in DR-BB rats is
not due to molecular mimicry, but is due to a
breakdown of the ﬁnely tuned immune balance
resulting in the selective activation of b cell-cytotoxic
effector T cells (Chung et al., 2000).
In this study, we investigated the role of Rat
Cytomegalovirus (RCMV) infection (e.g. rat equivalent
of HCMV) in the DP-BB rat. Here we report that RCMV
induces an accelerated onset of autoimmune diabetes in
DP-BB rats. The mechanism by which RCMV infection
induces autoimmune diabetes, however, is unknown.
Previous studies showed that RCMV infection did not
result in development of diabetes in a wide variety of rat
strains, including the DR-BB rat. Together with the
ﬁnding that the pancreatic islets are not infected upon
RCMV infection, these data indicate that RCMV-induced
lysis of the b cells is not likely to be the mechanism of
RCMV induced diabetes. Another way in which RCMV
might interfere in the diabetogenic process is by
modulating T cell immunity. In this study, we investigated
the cellular immune response against RCMV in vivo and
in vitro to get more insight into the mechanism(s) through
which RCMV modulates the autoimmune process in a rat
model predisposed to develop autoimmune diabetes.
RESULTS
Diabetes Onset after RCMV Infection
In order to investigate whether RCMV inﬂuences the
autoimmune process in DP-BB rats, animals were i.p.
infected with 2 £ 10
6pfu RCMVat 35 days of age. As a
result the mean diabetes onset was 67 ^ 13 days in this
group, which was signiﬁcantly accelerated when com-
pared to mock infected animals, which only developed
diabetes at the age of 80 ^ 10 days ðp ¼ 0:003Þ. Figure 1
shows the accelerating effect of RCMV on the diabetes
onset in DP-BB rats. In addition, the onset of insulitis
(intra-islet lymphocytic inﬁltration) was also accelerated
in RCMV infected rats (data not shown). In contrast,
DR-BB rats which do not spontaneously develop diabetes,
neither became diabetic, or developed insulitis after
RCMV infection (data not shown).
T Cell Subset Analysis In Vivo
The effect of RCMV infection on T cell subsets was
analyzed by performing ﬂow cytometric analysis on both
spleen and PBMNC from DPand DR-BB rats after RCMV
infection. Percentages of CD4
þ and CD8
þ T cell subsets
are listed in Table I. DR-BB rats showed a small increase
in the percentage of CD8
þ T cells 12 and 18 days after
FIGURE 1 Mean time of onset of diabetes. DP-BB rats were infected
with RCMVor mock infected at the age of 35 days and followed for the
development of diabetes (see “Materials and methods” section). RCMV
infection accelerated diabetes onset in DP-BB rats ðp ¼ 0:003Þ.
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uninfected controls (not signiﬁcant). DP-BB rats showed a
similar trend: the percentage of CD8
þ T cells is slightly
increased 14 days after RCMVinfection (data not shown).
Taken together, RCMV infection resulted in a slightly
increased CD8
þ T cell population in vivo in DP-BB as
well as DR-BB rats.
Proliferative Capacity of Splenocytes In Vitro after
RCMV Restimulation
Furthermore, the in vitro proliferation capacity of DR
splenocytes was examined by
3H-thymidine incorporation
18 days after RCMV infection. Since DP-BB splenic and
peripheral blood lymphocytes have markedly defective
proliferative responses in antigenic and mitogenic
stimulation assays, DR splenocytes were used to
determine in vitro proliferation upon RCMV stimulation
(Elder and Maclaren, 1983; Georgiou et al., 1988;
Georgiou and Bellgrau, 1989). DR splenocytes show a
strong RCMV speciﬁc proliferation (625 ^ 163dps)
in vitro after restimulation with RCMV infected
autologous ﬁbroblasts, as compared to the unstimulated
control (45 ^ 14dps). Since the RCMV speciﬁc response
(625 ^ 163dps) comprises about 50% of the response
triggered by Concanavalin A (1368 ^ 14dps), a poly-
clonal stimulator, these data suggest that over 50% of all
T cells proliferated. This T cell response is RCMV speciﬁc
because stimulation with uninfected ﬁbroblasts did
not induce such a strong proliferation (Fig. 2A). When
splenocytes were isolated 35 days after infection and
subsequently restimulated in vitro, a similar response was
observed, although the RCMV speciﬁc response was less
strong than 18 days after infection (data not shown).
In addition, the in vitro stimulated DR splenocytes were
labeled with mAb against TCRab and the percentage of
blastocytes was determined by ﬂow cytometric analysis.
Blastocytes can phenotypically be identiﬁed as TCRab
þ
and FSC
high. In accordance with the proliferation data as
assessed by
3H-Thymidine incorporation, restimulation of
RCMV infected splenocytes with autologous infected
ﬁbroblasts in vitro resulted in an increased blast
transformation (41%) compared to splenocytes restimu-
lated with uninfected ﬁbroblasts (15%). Con A stimulation
of both infected and uninfected splenocytes resulted in
a 99% blastocyte transformation (Fig. 2B). These results
conﬁrmed that RCMV infection of DR-BB rats results in
the generation of a strong proliferative T cell response,
probably involving almost 50% of all T cells.
T Cell Subset Analysis In Vitro
As shown in Table I RCMVinfection did not induce major
changes in the percentages of CD4
þ and CD8
þ T cells in
DP-BB as well as in DR-BB rats invivo and as a result the
CD4
þ/CD8
þ T cell ratio remained unaltered in vivo
(Fig. 3A). We subsequently analyzed T cell subset
distribution of DR-BB splenic T cells after restimulation
invitro. When DR splenic T cells were cultured for 4 days
without stimulation (medium control or stimulation with




þ T cell ratio increased (Fig. 3C), when
compared with uncultured splenocytes isolated 22 days
after RCMV infection (Fig. 3A; p , 0.05). Apparently,
the percentage of CD8
þ T cells decreased when splenic
T cells were cultured for 4 days in the absence of
stimulatory signals. Con A stimulation did not alter the
CD4
þ/CD8
þ ratio within blastoid T cells when compared
to unstimulated T cells. However, stimulation with
autologous RCMV infected Rat Embryonic Fibroblasts
(REF
þ) resulted in a signiﬁcantly lower CD4
þ/CD8
þ ratio
within splenic blastoid T cells when compared to ConA
stimulation (Fig. 3B; p ¼ 0:00028). These data thus show
that RCMV restimulation of splenic T cells resulted in a
decreased CD4
þ/CD8
þ ratio within blastoid T cells,
probably as a result of a preferential increase in the
percentage of blastoid CD8
þ T cells after RCMV
restimulation in vitro.
VbAnalysis of Splenic T Cells In Vivo and In Vitro
Data sofar showed that RCMV restimulation induced a
strong RCMV speciﬁc proliferation of DR-BB splenic
T cells in vitro. To test whether this response was
superantigen-driven, a Vb TCR analysis was performed
on splenic T cells after in vitro stimulation. The
percentages of three Vb TCR families: Vb16, Vb10.2
and Vb8.2 were measured by ﬂow cytometric analysis.
RCMV infection of DR-BB rats, however, did not affect
the percentages of these Vb TCR families within CD4
þ
TABLE I DR-BB rats show a small increase in the percentage of CD8þ T cells 12 and 18 days after RCMV infection in both spleen and peripheral
blood
Spleen Peripheral blood
%CD4+ T-cells %CD8+ T-cells %CD4+ T-cells %CD8+ T-cells
Untreated control 57.9 ^ 7.4* 34.7 ^ 4.2 72.8 ^ 2.9 25.5 ^ 2.7
6 days pi 63.3 ^ 0.7 31.4 ^ 1.3 77.0 ^ 2.1 21.1 ^ 1.7
12 days pi 53.3 ^ 8.5 40.4 ^ 7.3 67.3 ^ 4.3 30.7 ^ 4.4
18 days pi 57.2 ^ 6.5 38.6 ^ 5.7 66.6 ^ 6.8 31.8 ^ 6.8
*Data are represented as mean ^ SD. DR-BB rats were infected with 2.0 £ 10
6pfu RCMVat the age of 14 weeks. Both T cells from peripheral blood and splenocytes were
isolated (n ¼ 3/group) at 0, 6, 12 and 18 days after RCMV infection, labeled with FITC-conjugated OX8, PE-congugated OX35 and biotinylated R73mAb coupled to
Streptavidin Cychrome and analyzed on a ﬂow cytometer.
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þ T cell subsets when compared to uninfected
controlsinvivo(Fig.4A,B).Invitroasimilarpatterncould
be observed: percentages of the three Vb TCR families
did not alter after in vitro restimulation with RCMV
infected ﬁbroblasts (REFþ) within the blastoid T cell
population (REFþ versus ConA, Fig. 4C,D). In addition,
the resting T cell population did neither show changes in
Vb TCR family distribution after in vitro restimulation
with REFþ (REFþ versus REF2,F i g u r e4 E , F ) .
No changes could be observed between unstimulated
splenocytes and splenocytes stimulated with control
ﬁbroblasts (REF2versus medium, data not shown).
FIGURE 3 CD4
þ/CD8
þ T cell ratio of splenic T cells. A: RCMV infection of DR-BB rats (n ¼ 3/group) did not affect CD4
þ/CD8
þ ratio in splenic
T cells 22 days after infection compared to uninfected controls (n ¼ 2/group)
1.B :Invitro restimulation
2 of splenic T cells from RCMV infected DR-BB
rats with RCMV infected Embryonic Fibroblasts (REF
þ)( n ¼ 4/group) resulted in a signiﬁcant lower CD4
þ/CD8
þ ratio within splenic blastoid T cells
compared to ConA stimulation (n ¼ 3/group) ðp ¼ 0:00028Þ
. C: In vitro restimulation
2 of splenic T cells from RCMV infected DR-BB rats with
uninfected control Embryonic Fibroblasts (REF
2)( n ¼ 2/group) or non-stimulated (medium) (n ¼ 4/group) resulted in an increased CD4
þ/CD8
þ T cell
ratio compared to non-cultured splenic T cells (A; p , 0.05).
1Splenocytes were labeled with FITC-conjugated OX8, PE-conjugated OX35 and
biotinylated R73mAb coupled to Streptavidin Cychrome and analyzed on a ﬂow cytometer.
2Splenocytes were isolated from RCMV infected DR-BB
rats 18 days after infection and stimulated in vitro for 4 days with REF
þ, REF
2, ConA (5mg/ml) or left untreated.
FIGURE 2 Proliferation and blast transformation of DR-BB splenic T cells in vitro. A: DR-BB splenocytes showed a strong RCMV speciﬁc
proliferation in vitro after restimulation with infected autologous Rat Embryonal Fibroblasts (REF
þ; p , 0.05)
1 B1-3: FACS plots
2 of a representative
analysis showing blast transformation after restimulation in vitro with RCMV infected embryonic ﬁbroblasts (REF
þ, B1), ConA (B2) or non-infected
ﬁbroblasts (REF
2, B3).
1DR spleens were removed from RCMV infected rats 18 days after infection and splenocytes were stimulated in vitro with
infected or control Rat Embryonal Fibroblasts. As a positive control ConA stimulation (5mg/ml) was used. Medium represents the unstimulated control.
After 4 days of culture proliferation was determined by
3H-Thymidine incorporation.
2Splenocytes were labeled with biotinylated R73mAb coupled to
Streptavidin Cychrome and the percentage of blastocytes was determined by gating the R73
þ, FSC
high T cells.
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well as in vitro does not result in Vb TCR skewing for the
three Vb families tested.
DISCUSSION
Environmental factors and in particular viral infections
have been implicated in the etiology of various
AID (Whitton and Fujinami, 1999; Olson et al., 2001;
Rouse and Deshpande, 2002). Autoimmune diabetes type
1 is such an AID in which several viral infections
are suspected to play a role (Jun and Yoon, 2001).
One of the candidate viral infections is CMV, a virus that
is very common in the human population. Usually, a CMV
infection passes without clinical symptoms. However, in
immune compromised individuals reactivation can cause
severe morbidity and mortality (Plummer, 1973; Sinzger
and Jahn, 1996). Although there is a lot of data suggesting
that viruses such as CMV play a role in AID, evidence for
causal relationships is lacking. One of the problems is that
the virus causing the disease might have been cleared from
the patient at the time of diagnosis of AID (von Herrath,
2000). Animal models for AID could therefore provide
more direct evidence on the role of viral infections
in autoimmune pathology. The DP-BB rat, which
FIGURE 4 Analysis of three TCR Vb families: Vb16, Vb10.2 and Vb8.2 within splenic T cells of DR-BB rats. A-B: Vbanalysis of splenic T cells
22 days after RCMV infection
1. C-F: Vb analysis of splenic T cells of RCMV infected DR-BB rats restimulated in vitro with RCMV infected Rat
Embryonic Fibroblasts (REF




þ T cells were determined within the CD4
þ (A,C,E) or within the CD8
þ T cell subset (B,D,F) which is part of the blastoid T cell
population (C,D) or resting T cells (E,F).
1Splenocytes were labeled with FITC-conjugated Vb16, Vb10.2 or Vb8.2, PE-conjugated OX35 (aCD4) and
biotinylated R73mAb coupled to Streptavidin Cychrome and analyzed on a ﬂow cytometer.
2Splenocytes were isolated from RCMV infected DR-BB
rats 18 days after infection and stimulated in vitro for 4 days with REF
þ, REF
2, ConA (5mg/ml) or left untreated.
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animal model for autoimmune diabetes. In this report we
show that CMV infection accelerates the diabetogenic
process in DP-BB rats. One of the possible underlying
mechanisms of virus induced autoimmune diabetes could
be direct lytic infection of the pancreatic b cells.
This mechanism, however, seems not likely: PCR analysis
showed the presence of RCMV genome in only a few
islets isolated from infected BB rats (Hillebrands et al.
this volume). Furthermore, CMV infection did not
induce autoimmune diabetes in DR-BB rats, which are
predisposed to develop diabetes but do not spontaneously
develop autoimmune diabetes (Hillebrands et al. in
preparation). One of the key factors is that DR-BB rats
have regulatory RT6
þ T cells, whereas in DP-BB rats this
regulatory population, which under normal conditions
would prevent the autoimmunity to develop, is virtually
absent (Crisa et al., 1992; Mordes et al., 1996). Another
way in which RCMV might interfere in the diabetogenic
process is by modulating T cell subsets. To test this
hypothesis we investigated phenotype and proliferative
capacity of the cellular immune response against RCMV
in vivo and in vitro in BB rats. When DP-BB and DR-BB
rats were infected with RCMV, a slight increase in the
percentage of the CD8
þ T cell subset was found in DP-BB
as well as in DR-BB rats at 18 days after viral infection.
RCMV restimulation in vitro of splenic T cells resulted in
a strong RCMV speciﬁc proliferation in which DNA
synthesis comprises half of the mitotic events of
polyclonal stimulated T cells. Indeed, FACS analysis of
in vitro stimulated T cells showed that RCMV restimula-
tion resulted in blast transformation of a signiﬁcant part
(41%) of the T cell population. Preliminary data of
experiments, in which splenocytes were labeled with
CFSE and subsequently stimulated in vitro and followed
by FACS analysis, showed that approximately 8% of the T
cell population entered mitosis after RCMV stimulation.
The question arises whether RCMV acts here as a
superantigen or a polyclonal stimulator. In the case of
superantigenic stimulation RCMV peptide(s) could bind
sequentially to MHC class II proteins and the Vb chain of
the T cell receptor, thereby activating and expanding
predominantly CD4
þ T cells expressing the relevant Vb
family (Marrack et al., 1993). Superantigens also elicit
strong primary responses (Huber et al., 1996).
Several reports indeed suggest a role for viral protein(s)
with superantigenic activity in the development of
autoimmune diabetes. Conrad et al. found a selective
expansion of the TCR Vb7 chain among islet inﬁltrating
lymphocytes in two children with recent onset type 1
diabetes (Conrad et al., 1994). Luppi et al. showed TCR
Vb7 skewing of the peripheral blood lymphocytes
(PBL’s) of recently-diagnosed diabetic patients compared
to healthy individuals and patients with longterm diabetes,
but also a temporal relationship between acute enterovirus
infections and the increased percentage of Vb7 gene
transcripts (Luppi et al., 2000). Stauffer et al. proposed
that viral infections themselves might induce endogenous
superantigens, like human endogenous retroviral super-
antigen IDDMK1,222 via IFNa production causing
autoimmune disease like type 1 diabetes by activation
of autoreactive T cells (Stauffer et al., 2001). Dobrescu
et al. furthermore showed that a CMV gene product
was responsible for a superantigen-driven response:
Vb12-selective HIV1 replication was strongly promoted
by direct contact with CMV infected monocytes in a way
that is indistinguishable from the effect of known
superantigens (Dobrescu et al., 1995).
However, several of our data argue against a super-
antigenic nature of the strong invitroRCMV responses we
observed. Firstly, strong proliferative responses were only
found after invitro restimulation of invivo primed splenic
T cells. No such responses could be measured after
primary stimulation with RCMV in vivo. Secondly, only
expansion of CD8
þ T cells and not of CD4
þ T cells was
seen after RCMV infection in vivo and in vitro. Thirdly,
analysis of three Vb TCR
þ T cell subsets indicated that
RCMV infection did not result in speciﬁc Vb skewing.
These arguments rather support the view that RCMV
induces a kind of polyclonal T cell response. What might
then be the underlying mechanism of RCMV induced
acceleration of the autoimmune process in DP-BB rats?
We speculate that RCMV infection in diabetes prone
individuals results in polyclonal T cell stimulation,
thereby probably also activating and expanding existing
autoreactive T cells. As a result destructive insulitis and
consequently the development of diabetes is accelerated.
On top of such a bystander activation of autoreactive cells
also speciﬁc molecular mimicry between CMV epitopes
and b cell antigens could be involved (Hiemstra et al.,
2001). Further experiments on the functional character-
istics of this RCMV speciﬁc T cell response are needed to
determine the pathogenic capacity of those RCMV
activated T cells and their contribution to the eventual
lysis of the pancreatic b cells, in order to get more insight
in the role of the cellular immune response against RCMV
in RCMV induced accelerated autoimmune diabetes in
DP-BB rats.
In conclusion, RCMV restimulation of splenic T cells
in vitro results in a strong RCMV speciﬁc proliferation,
probably also including existing autoreactive T cells.
Invivo such a polyclonal stimulation might be responsible
for the accelerated destruction of pancreatic islets and




Diabetes Prone (DP-BB) and Diabetes Resistant (DR-BB)
BB rats were bred at the central animal facility of the
University of Groningen, The Netherlands. Original
breeding stocks were provided by the University of
Massachusetts, Worcester, MA, USA. The animals were
N. VAN DER WERF et al. 158raised under speciﬁc-pathogen-free (SPF) and viral-
antibody-free (VAF) conditions and had water and food ad
libitum. The University Ethical Board for Animal Studies
approved all animal experiments reported in this study.
Infection with RCMV
Rats of both sexes were injected intraperitoneally (i.p.)
with 2 £ 10
6pfn of RCMV at the age of 35 days. The
virus was isolated from salivary glands from infected rats
as described previously (Maastricht strain) (Bruggeman
et al., 1982). Control rats were left untreated or mock
infected. The latter was established by i.p. injection of
1ml saline containing an isolate of salivary gland obtained
from non-infected rats. Animals were observed twice a
week for physical well being and checked for weight loss.
When weight loss occurred, blood glucose levels were
measured in tail vein blood using a Reﬂolux
wS glucose
sensor (Boehringer Mannheim, Germany). Diabetes was
diagnosed when glucose levels exceeded 16mM. Diabetic
rats were killed at diagnosis and the remaining non-
diabetic animals were killed at the age of 140 days.
Stimulator Cells
Primary cultures of Rat Embryonic Fibroblasts (REF),
which where produced partly according to the methods of
Ross et al., were used as stimulator cells (Ross et al.,
1996). REF were passaged twice and cultured in Minimal
Earle’s Medium (Gibco) supplemented with 1% Non
Essential Amino Acids (Life technologies), 2mM
L-glutamin (Gibco), 100mg/ml gentamycin and 20%
Fetal Calf Serum (FCS) (Life technologies). When they
had grown to conﬂuence, the cells were serum-starved in
two steps (10% resp. 2% FCS) and they were infected with
RCMV for 24h, with a multiplicity of infection of 1.5pfu
RCMV per cell. After 24h culture medium was refreshed.
After another 48h the REF already showed signiﬁcant
signs of the RCMV induced cytopathic effects (cpe).
When more than 90% of the cells showed cpe, they were
harvested by adding PBS containing 1% trypsin and
0.5mM EDTA. After washing, the REF were ﬁxed in
1% paraformaldehyde for 10min at room temperature
(1 £ 10
7cells/ml). After washing the cells once with
0.2M glycine and once with culture medium, the REF
were ready for use. Remaining REF were resuspended
in Newborn Calf Serum (NCS) with 10% DMSO
(5 £ 10
5cells/ml) and stored at 2808C. Control stimula-
tor cells were prepared in the same way except for the
addition of virus.
In Vitro Stimulation
Splenocytes were isolated from DP-BB and DR-BB rats at
18and35daysafterRCMVinfection.Brieﬂy,spleenswere
dissected and pushed through an iron grid. After another,
ﬁnerﬁltrationstep,erythrocytesinthecellsuspensionwere
lysed with NH4Cl for 5min on ice. The splenocytes
(2 £ 10
5cells/well)wereincubatedfor4–6daysin200ml
of complete RPMI 1640 medium containing 10% FCS,
5mM sodium pyruvate, 5mM L-glutamine, 0.05mM 2-
ME and 5mg/ml gentamicin in 96 well roundbottom plates
inthepresenceofRCMVinfectedratembryonalﬁbroblasts
(REF
þ), uninfected REF (REF
2) at a responder:stimulator
ratio of 10:1 or complete medium. REF are prepared as
described under “stimulator cells”. As a positive control,
Concanavalin A (ConA) stimulation (5mg/ml) was used.
Splenocyteswere harvestedafter a4-day cultureperiodfor
ﬂow cytometric analysis and on days 4, 5 and 6 for
3H-
Thymidine incorporation.
In Vitro T Cell Proliferation Assay
On days 4, 5 and 6 after culture splenocytes were pulsed
with 1mCi
3H-Thymidine. After 16h of incubation, the
cells were harvested and the incorporated radioactivity
was counted using a liquid scintillation counter.
Flow Cytometry
Splenocytes and Peripheral Blood Mononuclear Cells
(PBMNC) were isolated from DP-BB and DR-BB rats 18
and 35 days after RCMVinfection. PBMNC were isolated
from cardiac blood by spinning at a rate of 2500rpm for
20min after 1:1 dilution of the blood with Phosphate
Buffered Saline (PBS). Buffycoats were taken and
incubated with NH4Cl for erythrocyte lysis. PBMNC
were resuspended in PBS containing 5% NCS, 0.5%
Dulbecco B and 0.03% sodium azide (DAB/NCS/azide).
Splenocytes were either freshly isolated or harvested after
4 days of invitro stimulation as described above. The cells
were incubated for 30min at 48C with FITC-conjugated
OX-8mAb (aCD8, Pharmingen), PE-conjugated
OX35mAb (aCD4, Pharmingen) and biotin-conjugated
R73mAb (aTCRab, Pharmingen) to determine CD4
þ
and CD8
þ T cell subsets. After washing, Streptavidin-
Cychrome (Pharmingen) was added to label biotin.
Splenocytes and PBMNC isolated from uninfected rats
were used as a control. To analyze Vb TCR speciﬁc
stimulation splenocytes were labeled with FITC-conju-
gated mAb’s Vb16, Vb10.2 and Vb8.2 (Pharmingen),
PE-conjugated OX35mAb and biotin-conjugated
R73mAb. After washing, Streptavidin-APC (Pharmin-
gen) was added to label biotin. Cell populations were
analyzed using an Epics Elite ﬂow cytometer (Coulter
Epics, Hialeah, USA).
Statistical Analysis
Statistical analysis was performed using a two-tailed
Student’s t test. Values of p , 0.05 were considered to be
signiﬁcant.
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